An Open-label, Fixed-sequence Phase I Clinical Trial to Evaluate the Effect of HS-10504 on the Pharmacokinetics of Midazolam in Patients With Non-small Cell Lung Cancer
3d agoen
From the article
Conditions : NSCLC Interventions : Drug: HS-10504； midazolam Sponsors : Jiangsu Hansoh Pharmaceutical Co., Ltd. Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial
doi.org·6d ago
Pharmaceutical LSD (MM120) Shows Promise in Treating Generalized Anxiety Disorder in UCSF Clinical Trials
Researchers at UCSF are testing MM120, a pharmaceutical form of LSD, as a treatment for generalized anxiety disorder (GAD). The treatment ha
sciencedaily.com·3mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.